You have access
Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with ≥42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer
DIRK RADES, TOBIAS BARTSCHT, CHRISTIAN IDEL, STEVEN E. SCHILD and SAMER G. HAKIM
Anticancer Research June 2018, 38 (6) 3653-3656; DOI: https://doi.org/10.21873/anticanres.12641
